We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$224B
AUM Growth
+$21B
Cap. Flow
+$7.48B
Cap. Flow %
3.33%
Top 10 Hldgs %
24.57%
Holding
10,190
New
1,427
Increased
4,227
Reduced
3,278
Closed
1,044

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$798M
2
T icon
AT&T
T
+$527M
3
MCHP icon
Microchip Technology
MCHP
+$472M
4
NFLX icon
Netflix
NFLX
+$446M
5
PNC icon
PNC Financial Services
PNC
+$444M

Top Sells

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$694M
2
KEY icon
KeyCorp
KEY
+$401M
3
DE icon
Deere & Co
DE
+$322M
4
CSX icon
CSX Corp
CSX
+$318M
5
NXPI icon
NXP Semiconductors
NXPI
+$314M

Sector Composition

Rank Sector Weight
1 Financials 5.91%
2 Technology 4.35%
3 Healthcare 4.25%
4 Industrials 4.06%
5 Consumer Discretionary 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BPTH
8951
DELISTED
Bio-Path Holdings Inc
BPTH
$8K ﹤0.01%
+33
New +$17.8K
ATNM icon
8952
CALL
Actinium Pharmaceuticals
ATNM
$30.2M
$7K ﹤0.01%
337
-733
-69% -$14.9K
ATNM icon
8953
PUT
Actinium Pharmaceuticals
ATNM
$30.2M
$7K ﹤0.01%
+333
New +$6.78K
NEON icon
8954
CALL
Neonode
NEON
$14.8M
$7K ﹤0.01%
+1,890
New +$6.17K
NSPR icon
8955
InspireMD
NSPR
$39.3M
$7K ﹤0.01%
+44
New +$6.98K
SUNW
8956
DELISTED
Sunworks, Inc.
SUNW
$7K ﹤0.01%
+2,022
New +$11.5K
VISL
8957
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$7K ﹤0.01%
13
-12
-48% -$7.73K
ICON
8958
DELISTED
Iconix Brand Group, Inc.
ICON
$7K ﹤0.01%
2,278
-7,972
-78% -$36K
GMO
8959
DELISTED
General Moly, Inc.
GMO
$6K ﹤0.01%
15,945
-37,366
-70% -$14.6K
SXE
8960
PUT
DELISTED
Southcross Energy Partners, L.P.
SXE
$6K ﹤0.01%
+10,000
New +$8.93K
THM
8961
International Tower Hill Mines
THM
$696M
$5K ﹤0.01%
+10,747
New +$5.14K
XPL icon
8962
Solitario Resources
XPL
$73.9M
$5K ﹤0.01%
+13,919
New +$5.43K
XTIA icon
8963
XTI Aerospace
XTIA
$60.4M
0
RSLS
8964
DELISTED
ReShape Lifesciences Inc. Common Stock
RSLS
$5K ﹤0.01%
+796
New +$68.5K
TRX icon
8965
CALL
TRX Gold Corp
TRX
$341M
$4K ﹤0.01%
12,100
-200
-2% -$81
QCLS
8966
Q/C Technologies Inc
QCLS
$22.5M
0
ICON
8967
CALL
DELISTED
Iconix Brand Group, Inc.
ICON
$4K ﹤0.01%
+1,430
New +$6.46K
NBSE
8968
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$3K ﹤0.01%
45
-127
-74% -$9.57K
OHGI
8969
DELISTED
One Horizon Group, Inc.
OHGI
$3K ﹤0.01%
+13,994
New +$4.43K
IMUC.WS
8970
DELISTED
ImmunoCellular Therapeutics Ltd.
IMUC.WS
$1K ﹤0.01%
+14,139
New +$342
AB icon
8971
AllianceBernstein
AB
$3.41B
-12,985
Closed -$388K
AAXJ icon
8972
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.85B
-168,950
Closed -$12.1M
ABUS icon
8973
Arbutus Biopharma
ABUS
$906M
-78,617
Closed -$574K
ACES icon
8974
ALPS Clean Energy ETF
ACES
$124M
-8,600
Closed -$217K
ACGL icon
8975
PUT
Arch Capital
ACGL
$33.5B
-15,900
Closed -$421K

Similar funds

Citadel Advisors's Q3 2018 Portfolio in Review

As of Q3 2018, Citadel Advisors held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Citadel Advisors deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.

By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.

  • Citadel Advisors's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
  • Citadel Advisors added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
  • Citadel Advisors's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
  • Citadel Advisors fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
  • Citadel Advisors's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
  • Citadel Advisors opened 1,427 new positions and closed 1,044 in Q3 2018.
  • Citadel Advisors's portfolio value rose 10% quarter-over-quarter to $224B.

Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.